Problem

Scientific researchers often need answers to highly specific, interconnected questions rather than simple keyword lookups. PubMed, Google Scholar, and similar tools can return large volumes of mostly irrelevant results, forcing researchers to spend hours screening papers and follow citation trails manually. The economic pain is not merely search time: missing one obscure but important paper can lead to poor research decisions or months of duplicated work. The core use case is helping scientists, physicians, and R&D teams assess complex or unfamiliar areas quickly—for example, finding prior methods, datasets, evidence, or relevant work before committing substantial resources to a research program.

Product / Service

Undermind is a web-based AI co-researcher and deep literature-search platform. A user describes a research topic conversationally, and the agent asks follow-up questions, performs multiple adaptive searches, evaluates papers, follows citation networks, and produces a ranked, cited report. It is designed to search by meaning rather than relying on a single keyword query; the platform can also read full-text papers and analyze figures, while allowing users to upload papers that are not openly accessible. Researchers can then interrogate the resulting library, generate syntheses and tables, brainstorm directions, and receive alerts about new literature.

The delivery model combines a free self-serve tier with paid Pro and Team plans and an enterprise offering. The principal benefit is precision and comprehensiveness: Undermind claims its searches return substantially more relevant results than conventional search, while showing inline citations and relevance information so users can verify the evidence. Its computationally intensive approach prioritizes depth over instant answers, making it best suited to consequential research questions rather than quick fact-checking.

Market

Undermind competes in AI-powered scientific literature search, research intelligence, and knowledge-synthesis software. Its alternatives include general academic indexes such as Google Scholar and PubMed, as well as AI research products such as Elicit and SciSpace. Undermind’s differentiation is its agentic, iterative search process and emphasis on discovering obscure or niche papers and estimating when a search is sufficiently complete, rather than simply summarizing the first page of results. The company targets a large population of scientific-literature users, especially academic researchers and pharmaceutical, biotech, engineering, and machine-learning R&D teams.

The company is active, was founded in 2023, and joined Y Combinator’s Summer 2024 batch. It is not best described as pre-revenue: Y Combinator reports paying users across medicine, ML, biotech, finance, and other fields, while Undermind says more than 1,000 GSK scientists use the product and that research groups and industry teams subscribe. Public company-profile data reports a $500,000 pre-seed round, and the product has both self-serve subscriptions and enterprise deployment, although no revenue figure is disclosed in the available evidence.